No results for ‘’
Aurobindo Pharma Ltd
₹1580.20
(0.25%)
Tue, 04 Aug 2026, 11:54 pm
Aurobindo Pharma Share Price Live Chart
1 Day
(0.25%)
No Result Found
Summary
Market Cap (in Cr)
83106.9
Net Profit (in Cr)
3483.57
P/B
2.06
Sector P/E
33.76
P/E
19.32
EV/EBITDA
9.39
Debt/Equity (Industry)
0.16
Interest Cover (Industry)
17.01
ROCE (Industry)
16.41
RONW (Industry)
14.52
ROE
11.15
ROCE
14.16
Debt/Equity
0.24
EPS (TTM)
61.09
Dividend Yield
0
Book Value
652.39
Interest Cover
12.08
Shareholding
| Shareholders | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 |
|---|---|---|---|---|---|
| Promoters | 51.82 | 51.82 | 51.82 | 51.82 | 51.82 |
| FII | 15.24 | 13.94 | 14.21 | 14.37 | 15.33 |
| DII | 25.87 | 27.68 | 27.60 | 26.93 | 26.23 |
| Public | 7.08 | 6.55 | 6.38 | 6.87 | 6.61 |
| Government | 0 | 0 | 0 | 0.00 | 0.00 |
Technical Analysis
Support and Resistance
| Type | R3 | R2 | R1 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 1825.93 | 1701.13 | 1640.67 | 1576.33 | 1515.87 | 1451.53 | 1326.73 |
| Fibonacci | 1701.13 | 1653.46 | 1624.01 | 1576.33 | 1528.66 | 1499.21 | 1451.53 |
| Camarilla | 1614.52 | 1603.08 | 1591.64 | 1576.33 | 1568.76 | 1557.32 | 1545.88 |
Pivots Level: Classic
R3
+249.60
1825.93
R2
+124.80
1701.13
R1
+64.33
1640.67
S1
-60.47
1515.87
S2
-124.80
1451.53
S3
-249.60
1326.73
Moving Average
Period
Value
10-EMA
1565.63
20-EMA
1556.83
30-EMA
1546.00
50-EMA
1519.76
100-EMA
1451.78
200-EMA
1360.94
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 21 May 2026 | board-meetings | Accounts | |
| 06 Apr 2026 | buyback | ||
| 09 Feb 2026 | board-meetings | Quarterly Results, Nine Months Results | |
| 05 Nov 2025 | board-meetings | Quarterly Results | |
| 12 Aug 2025 | agm | ||
| 04 Aug 2025 | dividend | ₹4.00 Dividend /Share | 08 Aug 2025 |
| 08 Jul 2025 | dividend | Interim Dividend - Rs. - 4 | 08 Aug 2025 |
| 30 Jul 2024 | agm | ||
| 26 Jul 2024 | agm | Annual General Meeting | 27 Aug 2024 |
| 18 Jul 2024 | buyback |
Peer Comparison
Aurobindo Pharma Ltd
Dr Reddys Laboratories Ltd
Sun Pharmaceutical Industries Ltd
Torrent Pharmaceuticals Ltd
Cipla Ltd
Divis Laboratories Ltd
Aurobindo Pharma Ltd About
Aurobindo Pharma is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services.
Industry
Pharmaceuticals - Indian - Bulk Drugs & Formln
Founded
1986
Headquarters
CEO
M R Kumar
Employees
Contact
Website
http://www.aurobindo.com
cs@aurobindo.com; investorgrievances@aurobindo.com
Phone
91-40-23736370
Location
Plot No 2 Maitrivihar, Behind Maithri Vanam Ameerpet, Hyderabad, Telangana, 500038
Aurobindo Pharma Ltd Company History
| Year | History |
|---|---|
| 2020 |
|
| 2021 |
|
| 2022 |
|
| 2023 |
|
| 2024 |
|
Deals
| Client Name | Deal Type | Order Side | QTY | Avg Price | Date |
|---|---|---|---|---|---|
| GOLDMAN SACHS (SINGAPORE) PTE.- ODI | block | Sell | 106228 | 1107 | 16 Oct 2025 |
| GOLDMAN SACHS BANK EUROPESE - ODI | block | Buy | 106228 | 1107 | 16 Oct 2025 |
| MARSHALL WACE INVESTMENT STRATEGIES SYSTEMATIC ALPHA PLUS FUND | block | Buy | 862 | 1160.1 | 25 Jan 2024 |
| SOCIETE GENERALE | block | Sell | 107558 | 1160.1 | 25 Jan 2024 |
| SOCIETE GENERALE | block | Buy | 1484323 | 1160.1 | 25 Jan 2024 |
| BNP PARIBAS ARBITRAGE | block | Sell | 1484323 | 1160.1 | 25 Jan 2024 |
| MARSHALL WACE INVESTMENT STRATEGIES EUREKA FUND | block | Buy | 53641 | 1160.1 | 25 Jan 2024 |
| MARSHALL WACE INVESTMENT STRATEGIES - EUREKA FUND | block | Buy | 106480 | 1160.1 | 25 Jan 2024 |
| MARSHALL WACE INVESTMENT STRATEGIES MARKET NEUTRAL TOPS FUND | block | Buy | 8134 | 1160.1 | 25 Jan 2024 |
| MARSHALL WACE INVESTMENT STRATEGIESGTOPS FUND | block | Buy | 27571 | 1160.1 | 25 Jan 2024 |
Frequently Asked Questions
1.What is the stock price of Aurobindo Pharma Ltd?
As of 05/08/2026 at 5:24 AM, Aurobindo Pharma Ltd shares are trading at ₹1580.20.
2.What is the market cap. of Aurobindo Pharma Ltd?
As of 05/08/2026, the market capitalization of Aurobindo Pharma Ltd is ₹90,872.30 crore.
3.When was Aurobindo Pharma Ltd founded?
Aurobindo Pharma Ltd was founded in 1986.
4.What are the P/E and P/B ratios of Aurobindo Pharma Ltd?
As of 05/08/2026, Aurobindo Pharma Ltd has a P/E ratio of 26.19 and a P/B ratio of 2.06.
5.How can I buy shares of Aurobindo Pharma Ltd?
You can buy shares of Aurobindo Pharma Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.
6.What is the shareholding pattern of Aurobindo Pharma Ltd?
As of March,2026, promoters hold 51.82% in Aurobindo Pharma Ltd, while FIIs, DIIs and public shareholders hold 15.24%, 25.87% and 7.08%, respectively.
7.Does Aurobindo Pharma Ltd pay dividends?
Yes, Aurobindo Pharma Ltd pays dividends to eligible shareholders. The latest dividend announced by the company was ₹₹4.00 Dividend /Share per share.
8.What is the dividend yield of Aurobindo Pharma Ltd?
As of 05 August, 2026, the dividend yield of Aurobindo Pharma Ltd stands at 0.25%.
9.What are the latest financial results of Aurobindo Pharma Ltd?
For January,2024, Aurobindo Pharma Ltd reported revenue of ₹31,403.00 crore and a net profit of ₹3,486.00 crore.
10.What is the Stock symbol of Aurobindo Pharma Ltd?
AUROPHARMA is the stock symbol of Aurobindo Pharma Ltd.
11.Who is the CEO of Aurobindo Pharma Ltd?
The CEO of Aurobindo Pharma Ltd is M R Kumar.